Literature DB >> 12620373

Mechanism-based partial inactivation of glutathione S-transferases by nitroglycerin: tyrosine nitration vs sulfhydryl oxidation.

Woo In Lee1, Ho Leung Fung.   

Abstract

Liver glutathione-S-transferases (GSTs) are responsible for the detoxification of electrophiles, and specifically for the metabolism of orally administered organic nitrates such as nitroglycerin (NTG). Recent studies showed that reactive nitrogen species produced by tetranitromethane (TNM), peroxynitrite, or the myeloperoxidase/H2O2/nitrite system can inactivate GST. It is not known whether NTG can similarly inactivate liver GSTs, and if shown, by what mechanism(s). We incubated purified GSTs with NTG, S-nitroso-N-acetylpenicillamine (SNAP), TNM, or vehicle (5% dextrose, D5W), followed by determination of GST activity. Incubation of GST with NTG and TNM caused significant decreases in GST activity whereas no changes were observed with SNAP or D5W. The relative GST activity (vs preincubation) was 73+/-14% for NTG, 37+/-8% for TNM, 98+/-13% for SNAP, and 98+/-9% for D5W, respectively. Exogenous glutathione (GSH) prevented both NTG- and TNM-induced changes in GST activity, consistent with the observed oxidative modification of GST, such as -SH oxidation and dimerization of oxidized GST. In contrast, NTG and TNM exhibited substantial differences in their ability to nitrate tyrosine (TYR) sites in GST. These results demonstrated that NTG can reduce the activity of its own metabolizing enzyme such as GST and this inhibitory effect of NTG was unlikely to be mediated through NO, as such, since SNAP had no effect on GST activity. The partial inactivation of GST by NTG appeared to involve -SH oxidation, but not TYR nitration. These findings provided the first evidence of mechanism-based protein inactivation by NTG, and may lend insight into the hepatic metabolism of NTG and other organic nitrates after repeated oral exposure.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12620373     DOI: 10.1016/s1089-8603(02)00183-0

Source DB:  PubMed          Journal:  Nitric Oxide        ISSN: 1089-8603            Impact factor:   4.427


  7 in total

1.  Differential metabolism of organic nitrates by aldehyde dehydrogenase 1a1 and 2: substrate selectivity, enzyme inactivation, and active cysteine sites.

Authors:  Pei-Suen Tsou; Nathaniel A Page; Sean G Lee; Sun Mi Fung; Wing Ming Keung; Ho-Leung Fung
Journal:  AAPS J       Date:  2011-08-05       Impact factor: 4.009

2.  Nitroglycerin alters matrix remodeling proteins in THP-1 human macrophages and plasma metalloproteinase activity in rats.

Authors:  Anu Shilpa Krishnatry; Sun Mi Fung; Daniel A Brazeau; David Soda; Ho-Leung Fung
Journal:  Nitric Oxide       Date:  2010-12-13       Impact factor: 4.427

3.  Direct gas measurements indicate that the novel cyclooxygenase inhibitor AZD3582 is an effective nitric oxide donor in vivo.

Authors:  L Christofer Adding; Per Agvald; Lars I Andersson; Bror Jonzon; Janet Hoogstraate; Lars E Gustafsson
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

Review 4.  Organic nitrate metabolism and action: toward a unifying hypothesis and the future-a dedication to Professor Leslie Z. Benet.

Authors:  Nathaniel A Page; Ho-Leung Fung
Journal:  J Pharm Sci       Date:  2013-05-13       Impact factor: 3.534

5.  Inactivation of hepatic enzymes by inhalant nitrite--in vivo and in vitro studies.

Authors:  Steven G Turowski; Kate E Jank; Ho-Leung Fung
Journal:  AAPS J       Date:  2007-07-27       Impact factor: 4.009

6.  Role of glutaredoxin-mediated protein S-glutathionylation in cellular nitroglycerin tolerance.

Authors:  Pei-Suen Tsou; Vamsi Addanki; Jessica A Haas; Nathaniel A Page; Ho-Leung Fung
Journal:  J Pharmacol Exp Ther       Date:  2009-02-17       Impact factor: 4.030

7.  Pharmacodynamics of in vivo nitroglycerin tolerance in normal conscious rats: effects of dose and dosing protocol.

Authors:  Ellen Q Wang; Joseph P Balthasar; Ho-Leung Fung
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.200

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.